Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox

Journal of Virology

Volumn 75, Issue 3, 2001, Pages 1205-1210

  Jackson, R J ^a   Ramsay, A J ^a   Christensen, C D ^a   Beaton, S ^a   Hall, D F ^a   Ramshaw, I A ^a  

^a CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; ECTROMELIA VIRUS; GENETIC RESISTANCE; IMMUNE RESPONSE; MORTALITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ECTROMELIA VIRUS; ECTROMELIA, INFECTIOUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECOMBINATION, GENETIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035154360     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.3.1205-1210.2001     Document Type: Article

References (45)

1. Biological effects of recombinant vaccinia virus-expressed interleukin 4
2. Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon
3. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
4. Use of recombinant viruses to deliver cytokines influencing the course of experimental bacterial infection
5. A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes
6. Effect of in vitro mutations in a vaccinia virus early promoter region monitored by herpes simplex virus thymidine kinase expression in recombinant vaccinia virus
7. In vivo effects of T helper cell type 2 cytokines on macrophage antigen-presenting cell induction of T helper subsets
8. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor alpha production
9. T cell memory
10. Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CD8 T cell subsets
11. - cells that make TH2 cytokines and help B cells
12. The pathogenesis of the acute exanthems - An interpretation based on experimental investigations with mousepox (infectious ectromelia of mice)
13. Mousepox
14. Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus
15. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity
16. Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3
17. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus
18. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses
19. Type 1 and type 2 cytokines in antiviral defense
20. + T lymphocytes and macrophage subsets in the control of a generalized virus infection
21. Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection
22. Elevated NK cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2
23. Importance of interferons in recovery from mousepox
24. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase
25. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
26. Fine mechanisms of ectromelia virus thymidine kinase-negative mutants avirulence
27. Interleukin-4 causes delayed virus clearance in influenza virus-infected mice
28. Species specificity of ectromelia virus and vaccinia virus interferon-γ binding proteins
29. Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia
30. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation
31. Mechanisms determining innate resistance to ectromelia virus infection in C57BL mice
32. A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice
33. Differentiation of human NK cells into NK1 and NK2 subsets
34. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo
35. A case for cytokines as effector molecules in the resolution of virus infection
36. Cytokines and immunity to viral infections
37. Cytokine-deficient CD8+ Tc1 cells reduced by IL-4: Retained inflammation and perform and Fas cytotoxicity but compromised long term killing of tumor cells
38. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines
39. Interleukin 4 (IL-4) blocks the IL-2-induced increased in natural killer activity and DNA synthesis of decidual CD16-CD56bright NK cells by inhibiting expression of the IL-2 receptor alpha, beta, and gamma
40. Acquisition of lymphokine-producing phenotype by CD4+ T cells
41. Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo
42. + T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses
43. Mechanism of protection during the early phase of a generalized viral infection. I. Contribution of phagocytes to protection against ectromelia virus
44. Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL/6 BALB/cByJ and AKR/J inbred mice
45. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: A comparative study with IL-4